Dr Stefaan Verbruggen
BEng, PhD, FHEA
Lecturer in Medical Technology
Engineering 224, Mile End
Feedback/ support hours: |
In Person - Tuesdays - 10-11am - ENG Room 224 Online - Thursdays - 1-2pm - Microsoft Teams (copy booking link into browser: https://shorturl.at/R3WZ8) |
Expertise: | Bone biomechanics and mechanobiology, Developmental biomechanics, cancer mechanobiology |
Research Centre: | |
Affiliations: |
Queen Mary+Emulate Organs-on-Chips Centre Centre for Predictive in vitro Models Organ-on-a-chip Technologies Network Visiting Academic, INSIGNEO Institute for in silico Medicine Fellow of the Higher Education Academy Member of the UK Biomedical Engineering Association Member of the European Society of Biomechanics Member of the Orthopaedic Research Society Member of the European Association for Cancer Research Member of the European Organ-on-a-Chip Society |
Brief Biography
Dr Stefaan Verbruggen is a Lecturer in Medical Technology at Queen Mary University of London. His research focuses on the mechanobiology of bone cells, and developing predictive in vitro models of cancer metastasis. As a Visiting Academic at the INSIGNEO Institute of in silico Medicine, Dr Verbruggen also builds predictive computational models of the biomechanics of metastatic bone lesions.
Prior to this, Dr Verbruggen conducted his PhD research in bone cell mechanobiology the Biomechanics Research Centre at the National University of Ireland Galway, followed by postdoctoral research in how fetal movements affect joint development in the Developmental Biomechanics Lab at Imperial College London.
Dr Verbruggen was then awarded a Marie Sklodowska-Curie Research Fellowship at Queen Mary University of London. As part of a collaboration with the Department of Biomedical Engineering at Columbia University, New York, Dr Verbruggen's investigated the mechanobiology of cancer cells, and how they metastasise to bone from other areas of the body.
Prior to this, Dr Verbruggen conducted his PhD research in bone cell mechanobiology the Biomechanics Research Centre at the National University of Ireland Galway, followed by postdoctoral research in how fetal movements affect joint development in the Developmental Biomechanics Lab at Imperial College London.
Dr Verbruggen was then awarded a Marie Sklodowska-Curie Research Fellowship at Queen Mary University of London. As part of a collaboration with the Department of Biomedical Engineering at Columbia University, New York, Dr Verbruggen's investigated the mechanobiology of cancer cells, and how they metastasise to bone from other areas of the body.